Amryt Pharma Overview
- Founded
- 2004

- Status
- Public
- Employees
- 88

- Stock Symbol
- AMYT

- Investments
- 4
- Share Price
- $2.80
- (As of Friday Closing)
Amryt Pharma General Information
Description
Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).
Contact Information
- Ivybridge House
- 1 Adam Street
- London WC2N 6LE
- England, United Kingdom
Amryt Pharma Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.80 | $2.80 | $0.98 - $3.24 | $501M | 179M | 65.3K | -$0.54 |
Amryt Pharma Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 541,271 | 268,107 | 59,680 | 73,537 |
Revenue | 180,381 | 58,124 | 17,095 | 14,411 |
EBITDA | (28,506) | (45,717) | (28,479) | (28,238) |
Net Income | (89,795) | (65,535) | (30,487) | (29,475) |
Total Assets | 507,435 | 534,347 | 80,834 | 96,084 |
Total Debt | 185,821 | 178,466 | 19,011 | 12,720 |
Amryt Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Amryt Pharma‘s full profile, request access.
Request a free trialAmryt Pharma Executive Team (8)
Amryt Pharma Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000 00.0 | Self | Board Member | 000 0000 |
000000 00000 00 | Amryt Pharma | Board Member | 000 0000 |
000000 00000 00 | Amryt Pharma | Founder, Chief Executive Officer & Board Member | 000 0000 |
0000000 0000 00 | Amryt Pharma | Board Member | 000 0000 |
0000000 00000 | Self | Board Member | 000 0000 |
Amryt Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmryt Pharma Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 000000000 | 24-Sep-2019 | 000000000000000000 | 00000 | Biotechnology | 000000 00000 00 |
000000 (0000000) | 18-Apr-2016 | 000000000000000000 | 000.00 | Drug Discovery | |
0000000 000000 | 18-Apr-2016 | 000000000000000000 | 000.00 | Energy Exploration | |
SomPharmaceuticals | 18-Apr-2016 | Merger/Acquisition | 00.000 | Therapeutic Devices |